Mawer Investment Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-339,387
Closed -$21.4M 97
2020
Q3
$21.4M Sell
339,387
-352,940
-51% -$24.5M 0.14% 76
2020
Q2
$53.3M Sell
692,327
-277,655
-29% -$21.3M 0.39% 51
2020
Q1
$72.5M Buy
969,982
+9,805
+1% +$678K 0.67% 39
2019
Q4
$62.4M Buy
960,177
+37,524
+4% +$2.44M 0.51% 44
2019
Q3
$58.5M Buy
922,653
+18,500
+2% +$1.21M 0.53% 43
2019
Q2
$61.1M Buy
904,153
+73,290
+9% +$4.82M 0.4% 62
2019
Q1
$54M Sell
830,863
-690
-0.1% -$45.9K 0.38% 60
2018
Q4
$52M Buy
831,553
+3,380
+0.4% +$236K 0.43% 60
2018
Q3
$63.9M Buy
828,173
+60,206
+8% +$4.55M 0.48% 57
2018
Q2
$54.4M Buy
767,967
+47,970
+7% +$3.39M 0.44% 60
2018
Q1
$54.3M Buy
719,997
+39,517
+6% +$3.14M 0.45% 59
2017
Q4
$48.8M Buy
680,480
+102,310
+18% +$7.77M 0.4% 60
2017
Q3
$46.8M Buy
578,170
+12,600
+2% +$963K 0.4% 63
2017
Q2
$40M Sell
565,570
-530
-0.1% -$35.3K 0.37% 65
2017
Q1
$38.5M Buy
566,100
+84,040
+17% +$5.91M 0.37% 67
2016
Q4
$34.5M Buy
482,060
+191,970
+66% +$14.3M 0.35% 67
2016
Q3
$23M Buy
+290,090
New +$23.6M 0.24% 70

Other funds holding GILD

Mawer Investment Management's GILD Position: Q4 2020 in Review

Mawer Investment Management sold out of Gilead Sciences (GILD) in Q4 2020, closing a stake of 339,387 shares — an estimated $21.4M sold.

Mawer Investment Management first reported a position in GILD in Q3 2016 and held it in 17 quarters. The position peaked at $72.5M in Q1 2020. 1,564 funds tracked by Wall St. Rank hold GILD as of Q4 2020.

  • Mawer Investment Management reported no remaining Gilead Sciences position as of Q4 2020 after selling out during the quarter.
  • Mawer Investment Management sold 339,387 Gilead Sciences shares in Q4 2020, an estimated $21.4M.
  • Mawer Investment Management first reported a position in Gilead Sciences in Q3 2016 and held it in 17 quarters.
  • Mawer Investment Management's Gilead Sciences position peaked at $72.5M in Q1 2020.
  • 1,564 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2020.

Based on Mawer Investment Management's 13F filing for Q4 2020, filed 9 Feb 2021.